Author： Hersh Elliot V. Lally Edward T. Moore Paul A.
Publisher： Informa Healthcare
ISSN： 1473-4877
Source： Current Medical Research and Opinion, Vol.21, Iss.8, 2005-08, pp. : 1217-1226
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Cyclooxygenase-2 inhibitors: promise or peril?
By Mengle-Gaw Laurel J. Schwartz Benjamin D.
Mediators of Inflammation, Vol. 11, Iss. 5, 2002-10 ,pp. :
Implementation of NICE guidance on Cox-II selective inhibitors
By Arnold K.
Journal of Clinical Excellence, Vol. 4, Iss. 3, 2002-07 ,pp. :
The Chemosensitizing and Radiosensitizing Eeffect of COX Inhibitors on Gliomas
By Lee D. H. Kim B. M. Hong S. H.
Radioprotection, Vol. 43, Iss. 5, 2008-09 ,pp. :
Selective COX-2 Inhibitors and Risk of Myocardial Infarction
Journal of Vascular Research, Vol. 42, Iss. 4, 2005-07 ,pp. :